<?xml version="1.0" encoding="UTF-8"?>
<p>Compounds 
 <bold>303</bold>–
 <bold>304</bold> were evaluated for their antibacterial activities against six pathogenic bacteria including 
 <italic>M. tetragenus</italic>, 
 <italic>S. aureus</italic>, 
 <italic>S. albus</italic>, 
 <italic>B. cereus</italic>, 
 <italic>B. subtilis</italic>, 
 <italic>E. coli</italic>. Compound 
 <bold>303</bold> showed antibacterial activity against 
 <italic>E. coli</italic> with the MIC value of 6.25 μg/mL, and 
 <bold>304</bold> exhibited a broad spectrum of antibacterial activities against six pathogenic with the MIC value ranging from 12.5 to 50 μg/mL (MIC values: 50 µg/mL for 
 <italic>M. tetragenus</italic>, 25 µg/mL for 
 <italic>S. aureus</italic>, &gt;50 µg/mL for 
 <italic>S. albus</italic>, 25 µg/mL for 
 <italic>B. cereus</italic>, 12.5 µg/mL for 
 <italic>B. subtilis</italic> and 50 µg/mL for 
 <italic>E. coli</italic>). Ciprofloxacin was used as a positive control (MIC values: 0.313 µg/mL for 
 <italic>M. tetragenus</italic> and 
 <italic>S. aureus</italic>, 0.625 µg/mL for 
 <italic>S. albus</italic>, 
 <italic>B. cereus</italic>, 
 <italic>B. subtilis</italic> and 
 <italic>E. coli</italic>) [
 <xref rid="B100-ijms-22-00959" ref-type="bibr">100</xref>].
</p>
